Unique Results from Swedish Study of HIV vaccine
A Swedish HIV vaccine study conducted by researchers at Karolinska Institutet (KI), Karolinska University Hospital and the Swedish Institute for Infectious Disease Control (SMI) has produced surprisingly good results. Over 90 per cent of the subjects in the phase 1 trials developed an immune response to HIV.
"Never has such a good result been seen with a vaccine of this type," says Professor Eric Sandström, Chief Physician at Karolinska University Hospital.
The trial subjects were vaccinated on three occasions with this vaccine using a needle-free method of injection. In order to enhance the effect, the researchers also gave the subjects a fourth dose of a vaccine in which parts of the HIV virus DNA had been integrated into another virus (vaccinia = the cowpox virus). This vaccine-based HIV vaccine is produced by the USA's National Institutes of Health and was donated for use in this Swedish study.
"Our vaccine is designed in such a way that it's able to protect against many of the circulating HIV types in Africa and the West," says Professor Britta Wahren at the SMI/KI.
Over 90 per cent of the trial subjects developed an immune response to HIV, and the vaccines have been tolerated well.
For further information, please contact:
Gunnel Biberfeld, Professor of Immunology, SMI and KI. Phone: +46-8-457 26 60, +46-73-346 26 60. E-mail: gunnel.biberfeld@smi.ki.se
Eric Sandström, Professor of Dermatovenerology, Chief Physician at Karolinska University Hospital. Phone: +46-8-616 25 71, +46-70-484 60 37. E-mail: eric.sandstrom@karolinska.se
Britta Wahren, Professor of Virology, SMI and KI. Phone:+46-8-457 26 30, +46-70-674 15 27. E-mail: britta.wahren@smi.ki.se
Last modified by: Jenny Hermansson 2006-08-31
They’re standing on the corner and they can’t speak English. I can’t even talk the way these people talk: Why you ain’t, Where you is, What he drive, Where he stay, Where he work, Who you be… And I blamed the kid until I heard the mother talk. And then I heard the father talk.
Everybody knows it’s important to speak English except these knuckleheads. You can’t be a doctor with that kind of crap coming out of your mouth. In fact you will never get any kind of job making a decent living.
People marched and were hit in the face with rocks to get an education, and now we’ve got these knuckleheads walking around. The lower economic people are not holding up their end in this deal. These people are not parenting. They are buying things for kids. $500 sneakers for what? And they won’t spend $200 for Hooked on Phonics.
...
What part of Africa did this come from? We are not Africans. Those people are not Africans; they don’t know a thing about Africa. With names like Shaniqua, Taliqua and Mohammed and all of that crap, and all of them are in jail.
...
We cannot blame the white people any longer.
More.
Brazil, India and South Africa will intensify their campaign for permanent seats on the United Nations Security Council when their leaders meet in the South African capital, Pretoria, on Oct. 17. President Luiz Inácio da Silva of Brazil, President Thabo Mbeki of South Africa and Indian Prime Minister Manmohan Singh will discuss U.N. reforms and other issues of common interest at the second IBSA (India, Brazil, South Africa) summit later this week.
All three countries are strong candidates to take up permanent seats on an expanded Security Council, and appear certain to support each other's efforts to represent their regions. This mutual endorsement will lend considerable weight to their respective bids, but at the same time could alienate them from potential supporters in their own regions.
IBSA was conceived in 2003 to counterbalance the powerful Group of Eight alliance of industrialised countries and to promote South-South cooperation. The three regional powers saw themselves as champions of developing world causes, and they felt that by forging closer ties between themselves they would be able to improve co-operation and trade between their regions.
More.
